KVSC News and Press, Khosla Ventures Acquisition Co. III

SPAC Khosla Ventures Acquisition (NASDAQ:KVSA) and Valo Health agreed to terminate a $2.8B business combination. KVSA gained 1.3%.  The SPAC and its target cited current market conditions, particularly in the biotechnology area, according to a statement yesterday. SPAC Khosla Ventur...

Jeff Smith’s 13F portfolio value increased from ~$3.93B to ~$4.69B this quarter. Starboard Value added Elanco Animal Health and eHealth, while dropping Advanced Auto Parts this quarter. The largest three individual stock positions are Corteva, Aecom, and NortonLifeLock. The...

Khosla Ventures Acquisition is combining with Valo Health in a ~$2.8B EV de-SPAC deal. Valo Health is a pre-revenue drug discovery platform that has high risk-reward characteristics. Sponsor incentives are setup to profit handsomely even in a negative-outcome scenario. As such, re...

Justin Sullivan/Getty Images News SPAC Khosla Ventures (KVSA) rose 1.3% in premarket trading on a report that the company is taking Valo Health LLC public in a deal that values the combined companies at about $2.8B. Khosla and Boston-based Valo Health plan to use the proceeds a...